Skip to main content

Advertisement

SpringerLink
Log in

Office-based Care of the Neurogenic Bladder Patient

  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Bladder dysfunction is common in neurologic disease and may be associated with significant secondary morbidity and mortality. Evaluation of neurogenic bladder patients is now taking place more frequently in an office setting. Flexible cystoscopy, videourodynamics, and office-based ultrasound imaging are commonly available in urologists’ offices. Emerging therapies, such as botulinum toxin injection, may reduce the need for surgical reconstruction and accelerate the shift of treatment of neurogenic bladder to the office setting. These complex patients, however, often have significant mobility issues that create barriers to care in the office setting. Optimal office design and setup as well as ancillary staff training are necessary to provide the most efficient and effective care of this patient population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Wyndaele JJ, Bruschini H, Madersbacher H, et al. Neurological patients need evidence-based urological care. Neurourol Urodyn. 2010;29:662–9.

    Article  PubMed  CAS  Google Scholar 

  2. •• Stöhrer M, Blok B, Castro-Diaz D, et al. EAU guidelines on neurogenic lower urinary tract dysfunction. Eur Urol. 2009;56:81–8. These guidelines should be read by anyone involved in the care of neurogenic bladder patients. Many would disagree with the recommendations as written, but they may be useful in that they focus on the need to generate more evidence-based data.

    Article  PubMed  Google Scholar 

  3. Linsenmeyer TA, Culkin D. APS recommendations for the urological evaluation of patients with spinal cord injury. J Spinal Cord Med. 1999;22:139–42.

    PubMed  CAS  Google Scholar 

  4. Abrams P, Agarwal M, Drake M, et al. A proposed guideline for the urological management of patients with spinal cord injury. BJU Int. 2008;101:989–94.

    Article  PubMed  Google Scholar 

  5. Consortium for Spinal Cord Medicine. Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers. J Spinal Cord Med. 2006;29:527–73.

    Google Scholar 

  6. de Sèze M, Ruffion A, Denys P, et al. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler. 2007;13:915–28.

    Article  PubMed  Google Scholar 

  7. • Wyndaele JJ, Kovindha A, Madersbacher H, et al. Neurologic urinary incontinence. Neurourol Urodyn. 2010;29:159–64. This is an excellent review of levels of evidence for treatments of neurogenic bladder.

    Article  PubMed  CAS  Google Scholar 

  8. Hunt GM. Open spina bifida: outcome for a complete cohort treated unselectively and followed into adulthood. Dev Med Child Neurol. 1990;32:108–18.

    Article  PubMed  CAS  Google Scholar 

  9. Mukherjee S. Transition to adulthood in spina bifida: changing roles and expectations. ScientificWorldJournal. 2007;7:1890–5.

    PubMed  Google Scholar 

  10. Oakeshott P, Hunt GM, Poulton A, et al. Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Dev Med Child Neurol. 2010;52:749–53.

    Article  PubMed  Google Scholar 

  11. Sepahpanah F, Burns SP, McKnight B, et al. Role of creatinine clearance as a screening test in persons with spinal cord injury. Arch Phys Med Rehabil. 2006;87:524–8.

    Article  PubMed  Google Scholar 

  12. DeWire DM, Owens RS, Anderson GA, et al. A comparison of the urological complications associated with long-term management of quadriplegics with and without chronic indwelling urinary catheters. J Urol. 1992;147:1069–71.

    PubMed  CAS  Google Scholar 

  13. Bih LI, Changlai SP, Ho CC, et al. Application of radioisotope renography with technetium-99m mercaptoacetyltriglycine on patients with spinal cord injuries. Arch Phys Med Rehabil. 1994;75:982–6.

    PubMed  CAS  Google Scholar 

  14. Matlaga BR, Kim SC, Watkins SL, et al. Changing composition of renal calculi in patients with neurogenic bladder. J Urol. 2006;175:1716–9.

    Article  PubMed  Google Scholar 

  15. Bodner DR, Witcher M, Resnick MI. Application of office ultrasound in the management of the spinal cord injury patient. J Urol. 1990;143(5):969–72.

    PubMed  CAS  Google Scholar 

  16. • American Urologic Association: Consensus statement. Available at http://www.auanet.org/content/guidelines-and-quality-care/policy-statements/c/consensus-statement-on-urologic-ultrasound-utilization.cfm. Accessed 4 January 2011. This should be required reading for any urologist doing and billing for any type of office ultrasound.

  17. American Institute of Ultrasound in Medicine: Guidelines and statements. Available at http://aium.org/publications/statements.aspx. Accessed 4 January 2011.

  18. Stohrer M, Castro-Diaz D, Chartier-Kastler E, Kramer G, Mattiasson A, Wyndaele JJ. Guidelines on neurogenic lower urinary tract dysfunction. Prog Urol. 2007;17:703–55.

    PubMed  CAS  Google Scholar 

  19. Fowler CJ, O’Malley KJ. Investigation and management of neurogenic bladder dysfunction. J Neurol Neurosurg Psychiatry. 2003;74 suppl 4:iv27–31.

    PubMed  Google Scholar 

  20. Kaplan SA, Chancellor MB, Blaivas JG. Bladder and sphincter behavior in patients with spinal cord lesions. J Urol. 1991;146:113–7.

    PubMed  CAS  Google Scholar 

  21. Weld KJ, Dmochowski RR. Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury. Urology. 2000;55:490–4.

    Article  PubMed  CAS  Google Scholar 

  22. Shenot PJ, Rivas DA, Watanabe T, Chancellor MB. Early predictors of bladder recovery and urodynamics after spinal cord injury. Neurourol Urodyn. 1998;17:25–9.

    Article  PubMed  CAS  Google Scholar 

  23. Schurch B, Schmid DM, Karsenty G, Reitz A. Can neurologic examination predict type of detrusor sphincterdyssynergia in patients with spinal cord injury? Urology. 2005;65:243–6.

    Article  PubMed  Google Scholar 

  24. Linsenmeyer MA, Linsenmeyer TA. Accuracy of predicting bladder stones based on catheter encrustation in individuals with spinal cord injury. J Spinal Cord Med. 2006;29:402–5.

    PubMed  Google Scholar 

  25. Kalisvaart JF, Katsumi HK, Ronningen LD, Hovey RM. Bladder cancer in spinal cord injury patients. Spinal Cord. 2010;48:257–61.

    Article  PubMed  CAS  Google Scholar 

  26. Davies B, Chen JJ, McMurry T, et al. Efficacy of BTA stat, cytology and surviving in bladder cancer surveillance over 5 years in patients with spinal cord injury. Urology. 2005;66:908–11.

    Article  PubMed  Google Scholar 

  27. Razdan S, Leboeuf L, Meinbach DS, Weinstein D, Gousse AE. Current practice patterns in the urologic surveillance and management of patients with spinal cord injury. Urology. 2003;61:893–6.

    Article  PubMed  Google Scholar 

  28. Liedl B. Catheter-associated urinary tract infections. Curr Opin Urol. 2001;11:75–9.

    Article  PubMed  CAS  Google Scholar 

  29. Morton SC, Shekelle PG, Adams JL, et al. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil. 2002;83:129–38.

    Article  PubMed  Google Scholar 

  30. Lee BB, Haran MJ, Hunt LM, et al. Spinal-injured neuropathic bladder antisepsis (SINBA) trial. Spinal Cord. 2007;45:542–50.

    Article  PubMed  CAS  Google Scholar 

  31. • Cameron AP, Wallner LP, Tate DG, et al. Bladder management after spinal cord injury in the United States 1972 to 2005. J Urol. 2010;184:213–7. This article shows that we still have a long way to go in the optimal bladder management of SCI patients.

    Article  PubMed  Google Scholar 

  32. Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:625–63.

    PubMed  Google Scholar 

  33. Gould CV, Umscheid CA, Agarwal RK, et al. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Guideline for the prevention of catheter-associated urinary tract infections, 2009 Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Available at: http://www.cdc.gov/hicpac/pdf/CAUTI/CAUTIguideline2009final.pdf. Accessed 16 December 2010.

  34. Amend B, Hennenlotter J, Schäfer T, et al. Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects. Eur Urol. 2008;53:1021–8.

    Article  PubMed  CAS  Google Scholar 

  35. Cameron AP, Clemens JQ, Latini JM, McGuire EJ. Combination drug therapy improves compliance of the neurogenic bladder. J Urol. 2009;182:1062–7.

    Article  PubMed  Google Scholar 

  36. Smaldone MC, Ristau BT, Leng WW. Botulinum toxin therapy for neurogenic detrusor overactivity. Urol Clin North Am. 2010;37:567–80.

    Article  PubMed  Google Scholar 

  37. • The Center for Universal Design, North Carolina State University. Removing Barriers to Health Care. Available at http://www.fpg.unc.edu/∼ncodh/pdfs/rbhealthcare.pdf. Accessed 16 December 2010. This excellent publication serves as an introduction to the concept of universal design. It gives practical advice on ways to improve accessibility in the medical office.

  38. Iwarsson S, Stahl A. Accessibility, usability and universal design—positioning and definition of concepts describing person-environment relationships. Disabil Rehabil. 2003;25:57–66.

    PubMed  CAS  Google Scholar 

  39. Jones KE, Tamari IE. Making our offices universally accessible: guidelines for physicians. CMAJ. 1997;156:647–56.

    PubMed  CAS  Google Scholar 

  40. •• US Department of Justice, Civil Rights Division, Disability Rights Section: Access to medical care for individuals with mobility disabilities. Available at http://www.ada.gov/medcare_mobility_ta/medcare_ta.htm. Accessed 16 December 2010. This pamphlet clearly illustrates the features of the accessible examination room and obligations of health care providers under Title III of the Americans With Disabilities Act.

  41. Zwarenstein M, Goldman J, Reeves S. Interprofessional collaboration: effects of practice-based interventions on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD000072.

Download references

Disclosure

Dr. Shenot has served as a consultant for Allergan and Medtronic and received grant support from Allergan and Tengion.

Dr. Moy has served as a consultant for Pfizer.

Author information

Authors and Affiliations

  1. Jefferson Medical College, Suite 1112, College Building, 1025 Walnut Street, Philadelphia, PA, 19107, USA

    Patrick J. Shenot

  2. Department of Urology, University of Florida, 1600 SW Archer Road, Room N-211, P.O. Box 100247, Gainesville, FL, 32610–0247, USA

    M. Louis Moy

Authors
  1. Patrick J. Shenot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Louis Moy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick J. Shenot.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shenot, P.J., Moy, M.L. Office-based Care of the Neurogenic Bladder Patient. Curr Bladder Dysfunct Rep 6, 74–80 (2011). https://doi.org/10.1007/s11884-011-0085-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-011-0085-8

Keywords

Search

Navigation